TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 66 filers reported holding TERNS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,743,791 | -58.3% | 5,118,050 | -27.4% | 0.00% | -60.0% |
Q2 2023 | $61,690,528 | -65.9% | 7,050,346 | -53.9% | 0.01% | -37.5% |
Q1 2023 | $180,980,510 | +140.9% | 15,285,516 | +107.2% | 0.01% | +14.3% |
Q4 2022 | $75,114,565 | +12440.0% | 7,378,641 | +7159.7% | 0.01% | – |
Q3 2022 | $599,000 | +137.7% | 101,639 | -0.0% | 0.00% | – |
Q2 2022 | $252,000 | -96.3% | 101,675 | -95.6% | 0.00% | -100.0% |
Q1 2022 | $6,895,000 | -65.2% | 2,321,458 | -17.1% | 0.00% | 0.0% |
Q4 2021 | $19,803,000 | -35.2% | 2,800,985 | -4.5% | 0.00% | -50.0% |
Q3 2021 | $30,564,000 | -17.5% | 2,933,162 | -3.0% | 0.00% | -33.3% |
Q2 2021 | $37,057,000 | -41.7% | 3,022,557 | +4.7% | 0.00% | -40.0% |
Q1 2021 | $63,530,000 | – | 2,887,738 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,099,309 | $13,015,819 | 9.59% |
VR Adviser, LLC | 3,619,522 | $42,855,140 | 8.37% |
Vivo Capital, LLC | 6,657,992 | $78,830,625 | 5.47% |
Fairmount Funds Management LLC | 2,040,000 | $24,153,600 | 4.15% |
Decheng Capital Management III (Cayman), LLC | 714,285 | $8,457,134 | 3.41% |
SILVERARC CAPITAL MANAGEMENT, LLC | 667,922 | $7,908,196 | 3.26% |
Ikarian Capital, LLC | 721,341 | $8,540,677 | 1.94% |
Orbimed Advisors | 7,619,135 | $90,210,558 | 1.77% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,448,275 | $40,827,576 | 1.72% |
CROSSPOINT FINANCIAL, LLC | 12,054 | $142,719 | 1.54% |